Literature DB >> 20595142

Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians.

Jill S Huppert1, Elizabeth Hesse, Grace Kim, Michael Kim, Patricia Agreda, Nicole Quinn, Charlotte Gaydos.   

Abstract

OBJECTIVES: To compare the accuracy (ie, correlation, sensitivity, specificity) of self-performed point-of-care (POC) tests with clinician-performed tests for trichomoniasis in adolescent women.
METHODS: Sexually experienced women aged 14-22 years (n=209) collected a vaginal swab and performed a POC test for trichomoniasis. Using a speculum, the clinician obtained vaginal swabs that were tested for trichomoniasis using the POC test, wet mount, culture and transcription-mediated amplification (TMA) using standard and alternative primers. Self and clinician results were compared with true positives, defined as either culture-positive or TMA-positive with both sets of primers.
RESULTS: Participants' mean age was 17.8 years; 87% were African-American; 74% reported vaginal itching or discharge and 51 (24%) had trichomoniasis. Over 99% correctly performed and interpreted her self-test. Self and clinician POC tests were highly correlated (95.7% agreement, κ 0.87). Compared with true positives, the sensitivity of the self-POC test was 78% (CI 65% to 89%), similar to that of the clinician-POC test (84%, CI 71% to 93%) and culture (82%, CI 69% to 92%), and significantly better than wet mount (39%, CI 26% to 54%). The specificity of the self-POC test was 99% (CI 96% to 100%), similar to that of the clinician-POC test (100%, CI 98% to 100%). The sensitivity of the self-POC test was not affected by vaginal symptoms or other variables.
CONCLUSIONS: Young women performing a self-POC test detected as many trichomoniasis infections as clinician-POC tests or culture, twice as many as wet mount and slightly fewer than an amplified test. Incorporating self-obtained or self-performed POC tests into routine practice could effectively increase the identification and treatment of trichomoniasis in this vulnerable population.

Entities:  

Mesh:

Year:  2010        PMID: 20595142      PMCID: PMC3221308          DOI: 10.1136/sti.2009.042168

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  28 in total

1.  Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples.

Authors:  Andrew Hardick; Justin Hardick; Billie Jo Wood; Charlotte Gaydos
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  The prevalence of trichomoniasis in young adults in the United States.

Authors:  William C Miller; Heidi Swygard; Marcia M Hobbs; Carol A Ford; Mark S Handcock; Martina Morris; John L Schmitz; Myron S Cohen; Kathleen Mullan Harris; J Richard Udry
Journal:  Sex Transm Dis       Date:  2005-10       Impact factor: 2.830

3.  Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples.

Authors:  G Madico; T C Quinn; A Rompalo; K T McKee; C A Gaydos
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

4.  Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.

Authors:  J R Schwebke; S L Hillier; J D Sobel; J A McGregor; R L Sweet
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

5.  Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis.

Authors:  J R Schwebke; S C Morgan; G B Pinson
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.

Authors:  Julius Schachter; Max A Chernesky; Dean E Willis; Paul M Fine; David H Martin; Deanna Fuller; Jeanne A Jordan; William Janda; Edward W Hook
Journal:  Sex Transm Dis       Date:  2005-12       Impact factor: 2.830

7.  Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections.

Authors:  W M Geisler; S Yu; M Venglarik; J R Schwebke
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

8.  STD care: variations in clinical care associated with provider sex, patient sex, patients' self-reported symptoms or high-risk behaviors, partner STD history.

Authors:  Janet S St Lawrence; Wen-Hung Kuo; Matthew Hogben; Daniel E Montaño; Danuta Kasprzyk; William R Phillips
Journal:  Soc Sci Med       Date:  2004-09       Impact factor: 4.634

9.  Diagnosis and clinical manifestations of bacterial vaginosis.

Authors:  D A Eschenbach; S Hillier; C Critchlow; C Stevens; T DeRouen; K K Holmes
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

10.  Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.

Authors:  Kakoli Roy; Susan A Wang; Martin I Meltzer
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  20 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Self-testing for Trichomonas vaginalis at home using a point-of-care test by women who request kits via the Internet.

Authors:  Charlotte A Gaydos; Mary Jett-Goheen; Mathilda Barnes; Laura Dize; Yu-Hsiang Hsieh
Journal:  Sex Health       Date:  2016-08-05       Impact factor: 2.706

3.  Accuracy and trust of self-testing for bacterial vaginosis.

Authors:  Jill S Huppert; Elizabeth A Hesse; Marianne Claire Bernard; Justin R Bates; Charlotte A Gaydos; Jessica A Kahn
Journal:  J Adolesc Health       Date:  2012-03-21       Impact factor: 5.012

4.  Acceptability of self-testing for trichomoniasis increases with experience.

Authors:  Jill S Huppert; Elizabeth A Hesse; Molly A Bernard; Yang Xiao; Bin Huang; Charlotte A Gaydos; Jessica A Kahn
Journal:  Sex Transm Infect       Date:  2011-07-27       Impact factor: 3.519

5.  Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection.

Authors:  Erik Munson; Timothy Kramme; Maureen Napierala; Kimber L Munson; Cheryl Miller; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

6.  Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment.

Authors:  Charlotte A Gaydos; Yu-Hsiang Hsieh; Mathilda Barnes; Nicole Quinn; Patricia Agreda; Mary Jett-Goheen; Pamela Whittle; Terry Hogan
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

Review 7.  Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men.

Authors:  Charlotte A Gaydos; Jeffrey D Klausner; Nitika Pant Pai; Helen Kelly; Cordelia Coltart; Rosanna W Peeling
Journal:  Sex Transm Infect       Date:  2017-07-06       Impact factor: 3.519

8.  Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.

Authors:  Jill S Huppert; Bin Huang; Chen Chen; Hassan Y Dawood; Raina N Fichorova
Journal:  J Infect Dis       Date:  2013-01-25       Impact factor: 5.226

9.  Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection.

Authors:  Kimber L Munson; Maureen Napierala; Erik Munson; Ronald F Schell; Timothy Kramme; Cheryl Miller; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

10.  Retrospective assessment of transcription-mediated amplification-based screening for Trichomonas vaginalis in male sexually transmitted infection clinic patients.

Authors:  Erik Munson; David Wenten; Paula Phipps; Roger Gremminger; Mary Kay Schuknecht; Maureen Napierala; Deb Hamer; Robin Olson; Ronald F Schell; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.